603127 昭衍新药
已收盘 03-19 15:00:00
资讯
新帖
简况
昭衍新药（603127）披露董事会会议安排公告，3月18日股价下跌0.14%
证券之星 · 03-18 22:03
昭衍新药（603127）披露董事会会议安排公告，3月18日股价下跌0.14%
股东清仓减持引发跌停 昭衍新药紧急调整方案
经济参考网 · 03-18 21:20
股东清仓减持引发跌停 昭衍新药紧急调整方案
股东拟“清仓式”减持，603127股价跌停！公司最新回应：减持力度超出市场预期
每日经济新闻 · 03-17 19:53
股东拟“清仓式”减持，603127股价跌停！公司最新回应：减持力度超出市场预期
3月17日昭衍新药（603127）龙虎榜数据：机构净卖出2.02亿元，北向资金净卖出269.05万元
证券之星 · 03-17 17:17
3月17日昭衍新药（603127）龙虎榜数据：机构净卖出2.02亿元，北向资金净卖出269.05万元
昭衍新药遭股东“清仓式”减持 业绩预增超两倍为何还留不住人？
21世纪经济报道 · 03-17 15:01
昭衍新药遭股东“清仓式”减持 业绩预增超两倍为何还留不住人？
异动快报：昭衍新药（603127）3月17日13点21分触及跌停板
证券之星 · 03-17 13:25
异动快报：昭衍新药（603127）3月17日13点21分触及跌停板
昭衍新药股东顾晓磊及其一致行动人顾美芳拟清仓式减持公司A股股份
北京商报 · 03-16
昭衍新药股东顾晓磊及其一致行动人顾美芳拟清仓式减持公司A股股份
昭衍新药股东拟减持不超过4.1%股份，减持期为3月20日至6月19日
美股速递 · 03-16
昭衍新药股东拟减持不超过4.1%股份，减持期为3月20日至6月19日
昭衍新药(06127)进一步认购金融产品
智通财经 · 03-16
昭衍新药(06127)进一步认购金融产品
每周股票复盘：昭衍新药（603127）H股月报显示股本无变动
证券之星 · 03-08
每周股票复盘：昭衍新药（603127）H股月报显示股本无变动
港股医药股走强 昭衍新药涨近4%
南方财经网 · 03-06
港股医药股走强 昭衍新药涨近4%
港股医药外包概念股震荡走强，昭衍新药、药明生物、维亚生物均涨超3%
每日经济新闻 · 02-10
港股医药外包概念股震荡走强，昭衍新药、药明生物、维亚生物均涨超3%
每周股票复盘：昭衍新药（603127）注销129,114股库存股
证券之星 · 02-08
每周股票复盘：昭衍新药（603127）注销129,114股库存股
每周股票复盘：昭衍新药（603127）股东周志文减持1497.9万股
证券之星 · 02-01
每周股票复盘：昭衍新药（603127）股东周志文减持1497.9万股
AI重塑医药生产力，为何超六成医药企业拥抱钉钉？
上观新闻 · 01-30
AI重塑医药生产力，为何超六成医药企业拥抱钉钉？
昭衍新药：周志文已减持1497.90万股
南方财经网 · 01-29
昭衍新药：周志文已减持1497.90万股
实验猴涨价推动昭衍新药业绩反转，预计2025年扣非净利同比增长超9倍
每日经济新闻 · 01-26
实验猴涨价推动昭衍新药业绩反转，预计2025年扣非净利同比增长超9倍
每周股票复盘：昭衍新药（603127）股东周志文减持1010.37万股
证券之星 · 01-25
每周股票复盘：昭衍新药（603127）股东周志文减持1010.37万股
1月23日昭衍新药现2笔折价12.81%的大宗交易 合计成交2.13亿元
证券之星 · 01-23
1月23日昭衍新药现2笔折价12.81%的大宗交易 合计成交2.13亿元
去年四季度买回昭衍新药、中国东航，中欧基金葛兰：一季度医药板块有望延续结构性行情
澎湃新闻 · 01-22
去年四季度买回昭衍新药、中国东航，中欧基金葛兰：一季度医药板块有望延续结构性行情
加载更多
公司概况
公司名称：
北京昭衍新药研究中心股份有限公司
所属行业：
研究和试验发展
上市日期：
2017-08-25
主营业务：
北京昭衍新药研究中心股份有限公司的主营业务是以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是药物非临床研究服务、临床服务及其他、实验模型供应。
发行价格：
12.51
{"stockData":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":28.55,"timestamp":1773903600000,"preClose":29.28,"halted":0,"volume":15085170,"delay":0,"changeRate":-0.0249,"floatShares":630000000,"shares":749000000,"eps":0.3004,"marketStatus":"已收盘","change":-0.73,"latestTime":"03-19 15:00:00","open":28.88,"high":29.24,"low":28.4,"amount":432000000,"amplitude":0.0287,"askPrice":28.56,"askSize":85,"bidPrice":28.55,"bidSize":231,"shortable":0,"etf":0,"ttmEps":0.3004,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773970200000},"marketStatusCode":5,"adr":0,"adjPreClose":29.28,"symbolType":"stock","openAndCloseTimeList":[[1773883800000,1773891000000],[1773896400000,1773903600000]],"highLimit":32.21,"lowLimit":26.35,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":749348220,"isCdr":false,"pbRate":2.63,"roa":"--","peRate":95.039947,"roe":"1.0%","epsLYR":0.1,"committee":0.586014,"marketValue":21394000000,"turnoverRate":0.0239,"status":1,"hkstockBrief":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":16.7,"timestamp":1773907695003,"preClose":17.11,"halted":0,"volume":2251172,"delay":0,"premium":"-48.62"},"floatMarketCap":17997000000},"requestUrl":"/m/hq/s/603127","defaultTab":"news","newsList":[{"id":"2620997254","title":"昭衍新药（603127）披露董事会会议安排公告，3月18日股价下跌0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620997254","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620997254?lang=zh_cn&edition=full","pubTime":"2026-03-18 22:03","pubTimestamp":1773842596,"startTime":"0","endTime":"0","summary":"截至2026年3月18日收盘，昭衍新药报收于29.28元，较前一交易日下跌0.14%，最新总市值为219.41亿元。该股当日开盘28.72元，最高29.89元，最低28.6元，成交额达8.19亿元，换手率为4.48%。近日，昭衍新药发布H股公告，披露公司董事会将于2026年3月30日举行会议，以考虑及通过本集团截至2025年12月31日止的年度业绩，考虑建议派发末期股息（如有），以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800040411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK1141","BK0216","BK1576","603127"],"gpt_icon":0},{"id":"2620259742","title":"股东清仓减持引发跌停 昭衍新药紧急调整方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2620259742","media":"经济参考网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620259742?lang=zh_cn&edition=full","pubTime":"2026-03-18 21:20","pubTimestamp":1773840000,"startTime":"0","endTime":"0","summary":"3月16日晚间，CRO（医药研发外包服务）头部企业昭衍新药（603127.SH）披露股东“清仓式”减持计划，引发市场剧烈震荡。3月17日公司A股股价跌停、H股下跌超11%，公司随后迅速发布更正公告，下调减持比例并优化减持方式。对此，《经济参考报》记者致电昭衍新药，尝试了解公司发布更正公告下调股东减持比例是否受到股价下跌的影响，昭衍新药方面表示：“确实有这方面的考虑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603183676233241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603127","BK0216","06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2620424582","title":"股东拟“清仓式”减持，603127股价跌停！公司最新回应：减持力度超出市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2620424582","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620424582?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:53","pubTimestamp":1773748380,"startTime":"0","endTime":"0","summary":"3月17日，CRO龙头昭衍新药A股跌停，H股重挫超10%。 引发此次股价地震的，是一则“清仓式”减持公告。 公司3月16日晚间对外披露关于股东减持A股股份计划公告。上述股东此前已在陆续减持，但此次减持力度超出市场预期，因此市场反应较大。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2026-03-17/doc-inhrieim8011455.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-03-17/doc-inhrieim8011455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603127","BK0216"],"gpt_icon":0},{"id":"2620344094","title":"3月17日昭衍新药（603127）龙虎榜数据：机构净卖出2.02亿元，北向资金净卖出269.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620344094","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620344094?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:17","pubTimestamp":1773739021,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年3月17日公布的交易公开信息显示，昭衍新药因有价格涨跌幅限制的日收盘价格跌幅偏离值达到7%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年3月17日收盘，昭衍新药报收于29.32元，下跌10.01%，换手率4.57%，成交量28.83万手，成交额8.55亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出2.02亿元，北向资金合计净卖出269.05万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700029659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","06127","603127","BK1576","BK1141"],"gpt_icon":0},{"id":"2620024446","title":"昭衍新药遭股东“清仓式”减持 业绩预增超两倍为何还留不住人？","url":"https://stock-news.laohu8.com/highlight/detail?id=2620024446","media":"21世纪经济报道","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620024446?lang=zh_cn&edition=full","pubTime":"2026-03-17 15:01","pubTimestamp":1773730898,"startTime":"0","endTime":"0","summary":"3月17日，对于CRO（医药研发外包服务）龙头昭衍新药（603127.SH，06127.HK）的投资者而言，是一个颇不平静的交易日。继前一日发布股东减持计划公告后，昭衍新药今日开盘即跳空低开，盘中一度重挫逾9%，截至发稿时股价仍徘徊在底部区域，市场恐慌情绪可见一斑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603173674511327.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603173674511327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","603127","BK1576","BK1141","BK0216"],"gpt_icon":0},{"id":"2620649448","title":"异动快报：昭衍新药（603127）3月17日13点21分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2620649448","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620649448?lang=zh_cn&edition=full","pubTime":"2026-03-17 13:25","pubTimestamp":1773725124,"startTime":"0","endTime":"0","summary":"证券之星3月17日盘中消息，13点21分昭衍新药触及跌停板。其所属行业医疗服务目前下跌。领涨股为*ST生物。该股为健康中国，创新药，医药概念热股，当日健康中国概念上涨0.69%，创新药概念上涨0.41%，医药概念上涨0.16%。3月16日的资金流向数据方面，主力资金净流出1388.82万元，占总成交额4.77%，游资资金净流出1183.65万元，占总成交额4.07%，散户资金净流入2572.47万元，占总成交额8.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700019711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","603127","06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2619469088","title":"昭衍新药股东顾晓磊及其一致行动人顾美芳拟清仓式减持公司A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619469088","media":"北京商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619469088?lang=zh_cn&edition=full","pubTime":"2026-03-16 22:05","pubTimestamp":1773669930,"startTime":"0","endTime":"0","summary":"北京商报讯3月16日晚间，昭衍新药（603127）发布公告显示，公司股东顾晓磊及其一致行动人顾美芳拟清仓式减持公司A股股份。具体来看，顾晓磊及其一致行动人顾美芳目前分别持有公司A股股份2042.05万股、1032.2万股，持股比例分别约为2.73%、1.38%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603163673427859.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603163673427859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK0216","159982","BK1576","603127","06127","399300"],"gpt_icon":0},{"id":"1192887526","title":"昭衍新药股东拟减持不超过4.1%股份，减持期为3月20日至6月19日","url":"https://stock-news.laohu8.com/highlight/detail?id=1192887526","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192887526?lang=zh_cn&edition=full","pubTime":"2026-03-16 18:47","pubTimestamp":1773658035,"startTime":"0","endTime":"0","summary":"昭衍新药（603127.SS）近日发布公告称，公司部分股东计划通过集中竞价或大宗交易方式，在2024年3月20日至6月19日期间，合计减持不超过公司总股本4.1%的股份。\n此次减持计划涉及多位股东，其减持行为将根据市场情况、公司股价等因素择机进行。减持股份来源均为公司首次公开发行前已持有的股份。\n股东减持可能会对二级市场股价造成一定压力，投资者需关注相关风险。公司表示，本次减持计划不会导致公司控制权发生变更，也不会对公司的持续性经营产生重大影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","603127"],"gpt_icon":0},{"id":"2619060455","title":"昭衍新药(06127)进一步认购金融产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2619060455","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619060455?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:13","pubTimestamp":1773652406,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布公告，于2026年3月16日(交易时间后)，本集团成员公司透过中信证券及其附属公司认购该等中信证券金融产品且于本公告日期仍未到期的该等中信证券金融产品合计投资总额为人民币4.6亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414330.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","159940","06127","BK1576","BK0216","603127"],"gpt_icon":0},{"id":"2617986668","title":"每周股票复盘：昭衍新药（603127）H股月报显示股本无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2617986668","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617986668?lang=zh_cn&edition=full","pubTime":"2026-03-08 01:20","pubTimestamp":1772904023,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，昭衍新药报收于33.36元，较上周的36.73元下跌9.18%。本周关注点公司公告汇总：H股公告显示截至2026年2月28日股本及已发行股份无变动公司公告汇总H股公告：2月月报表北京昭衍新药研究中心股份有限公司提交截至2026年2月28日的证券变动月报表。公司H股和A股的法定/注册股本、已发行股份及库存股数量均无变动。本月H股和A股的已发行股份数目保持不变，库存股数量亦无变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127","BK0216","BK1141","BK1576"],"gpt_icon":0},{"id":"2617505262","title":"港股医药股走强 昭衍新药涨近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617505262","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617505262?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:05","pubTimestamp":1772762708,"startTime":"0","endTime":"0","summary":"南方财经3月6日电，港股医药股走强，截至发稿，昭衍新药(06127.HK)涨3.60%、维亚生物(01873.HK)涨2.87%、金斯瑞生物(01548.HK)涨1.75%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603063664173436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["159718","603127","BK1141","BK0216","BK1576","06127"],"gpt_icon":0},{"id":"2610169639","title":"港股医药外包概念股震荡走强，昭衍新药、药明生物、维亚生物均涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610169639","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610169639?lang=zh_cn&edition=full","pubTime":"2026-02-10 10:08","pubTimestamp":1770689294,"startTime":"0","endTime":"0","summary":"每经AI快讯，2月10日，港股医药外包概念股震荡走强，昭衍新药(06127.HK)、药明生物(02269.HK)、维亚生物(01873.HK)均涨超3%，泰格医药(03347.HK)、药明康德(02359.HK)、凯莱英(06821.HK)均涨超2.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602103646424498.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602103646424498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1242518857.USD","LU1880383366.USD","159718","LU0181495838.USD","LU0456846285.SGD","LU1794554557.SGD","LU0359201612.USD","BK1610","LU0140636845.USD","BK1589","02269","LU0516422440.USD","01873","SG9999002562.SGD","LU0043850808.USD","603127","BK1521","LU0052750758.USD","LU0307460666.USD","LU0327786744.USD","LU2039709279.SGD","LU0417516738.SGD","LU0359202008.SGD","LU0516422952.EUR","LU0572944931.SGD","LU0320764599.SGD","SG9999002463.SGD","LU0819121731.USD","LU1720050803.USD","06127","LU0039217434.USD","LU0588546209.SGD","LU0348735423.USD","LU0051755006.USD","BK0216","LU0417516902.SGD","LU0516423174.USD","LU0823426308.USD","LU0326950275.SGD","LU0516423091.SGD","LU0708995583.HKD","LU0348825331.USD","LU1688375341.USD","LU0823426480.USD","LU0979878070.USD","LU0456827905.SGD","IE00B0JY6N72.USD","LU1242518931.SGD","BK1141","LU3063872942.SGD"],"gpt_icon":0},{"id":"2609523713","title":"每周股票复盘：昭衍新药（603127）注销129,114股库存股","url":"https://stock-news.laohu8.com/highlight/detail?id=2609523713","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609523713?lang=zh_cn&edition=full","pubTime":"2026-02-08 01:32","pubTimestamp":1770485532,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，昭衍新药报收于37.81元，较上周的38.01元下跌0.53%。本周，昭衍新药2月6日盘中最高价报39.05元。本周关注点公司公告汇总：昭衍新药注销129,114股库存股，注册股本相应减少。A类普通股注册股本减少129,114股，本月底注册股本为630,353,014股，H类普通股无变动。库存股减少129,114股，因注销库存股份所致，事件发生日期为2026年1月7日，经2025年6月18日股东大会通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK1576","BK1141","06127","BK0216"],"gpt_icon":0},{"id":"2608727350","title":"每周股票复盘：昭衍新药（603127）股东周志文减持1497.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608727350","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608727350?lang=zh_cn&edition=full","pubTime":"2026-02-01 01:49","pubTimestamp":1769881750,"startTime":"0","endTime":"0","summary":"来自股本股东变化：股东周志文于2026年1月24日至28日合计减持487.53万股，占总股本0.6506%。交易信息汇总1月28日昭衍新药发生2笔大宗交易，成交金额8830.64万元。股本股东变化股东周志文于2026年1月24日至2026年1月28日间合计减持487.53万股，占公司目前总股本的0.6506%，变动期间该股股价下跌7.65%，截止1月28日收盘报37.93元。周志文决定提前终止减持计划，实际减持情况与披露计划一致，未违反相关承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020100000362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","603127","BK0216","BK1576","06127"],"gpt_icon":0},{"id":"2607025472","title":"AI重塑医药生产力，为何超六成医药企业拥抱钉钉？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607025472","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607025472?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:43","pubTimestamp":1769737380,"startTime":"0","endTime":"0","summary":"以“AI重塑医药生产力”为主题的2026医药钉峰会日前在沪召开，共探人工智能技术如何驱动赋能医药行业。AI自动完成数据抓取、分析与预警，让人人皆可成为开发者，大幅提升了业务响应的敏捷性。此外，AI正成为药企全球化协同的基石。AI不再是遥远的技术概念，而是已经成为医药行业提质、增效、创新的核心驱动要素。随着AI技术产品持续完善、行业生态日益繁荣，一场以人工智能为核心的医药生产力革命，正从蓝图加速照进现实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130095032a466dcda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130095032a466dcda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0396098781.USD","BK1615","LU0431992006.USD","LU0708995153.HKD","LU1323998911.USD","LU0096374516.USD","BK1610","LU0214875030.USD","LU1504937902.USD","LU1720051017.SGD","LU0821914370.USD","LU0320764755.SGD","LU0588545904.SGD","LU0871576103.HKD","LU0143863784.USD","IE00B0169N27.USD","LU0531971595.HKD","LU2097828631.EUR","LU0502904849.HKD","SG9999000327.SGD","LU1282649141.HKD","LU0143863198.USD","LU0315178854.USD","LU1568876251.USD","LU1880383366.USD","LU0672654166.SGD","LU0572944931.SGD","BK1575","BK1608","LU0051755006.USD","LU0648000940.SGD","LU1211504680.USD","LU0011963245.USD","LU0642271901.SGD","LU0196878994.USD","LU1794554557.SGD","LU0359201612.USD","SG9999001226.SGD","LU1515016050.SGD","LU1969619763.USD","LU1048484197.HKD","LU0455707207.USD","LU0577902298.EUR","LU1439103000.SGD","BK1574","LU0499858602.USD","IE00BMPRXN33.USD","LU0577902611.USD","LU0326950275.SGD","LU1115378108.SGD","LU0784639295.USD","LU0577902371.SGD","LU1044876610.USD","02157","000538","LU0173614495.USD","LU0588546209.SGD","IE0032431581.USD","LU1044874839.SGD","BK1584","IE0008368304.USD","LU0106259558.USD","LU0117844026.USD","LU1328615791.USD","HK0000306701.USD","HBBD.SI","LU0593848301.USD","LU1282649067.USD","LU0762542818.HKD","HK0000320264.USD","LU1719994722.HKD","LU0979878070.USD","LU0048597586.USD","LU0516422366.SGD","SG9999014674.SGD","LU0029874905.USD","BK1515","ALBmain","LU0868486357.SGD","LU0130103400.USD","LU0348788117.USD","LU0762541174.USD","SG9999006514.SGD","06127","LU1655091459.SGD","LU0607220059.USD","LU0572939691.SGD","LU0823413587.USD","LU0823397285.USD","LU0293314216.USD","LU0561508036.HKD","LU0149534421.HKD","LU0287142896.SGD","LU0823397103.USD","LU0469268626.HKD","LU2087589342.USD","LU1282651048.USD","SG9999002562.SGD","LU0449515922.USD","LU0132412106.USD","LU0456827905.SGD","LU0417516902.SGD","LU0149721374.USD","LU1831875114.USD","LU0127658192.USD","LU0886674414.USD","LU2399975544.HKD","LU0819123356.HKD","LU0516423174.USD","LU0862451837.USD","89988","LU0348783662.USD","LU0328353924.USD","LU0417516571.SGD","LU0823040885.USD","LU1051768304.USD","LU1282651121.HKD","LU0039217434.USD","LU2293587155.HKD","LU0320764599.SGD","LU2097829019.USD","01801","LU1568876335.HKD","SG9999006597.SGD","LU1196710864.SGD","LU0117841782.USD","LU2328871848.SGD","BK1142","LU1548497426.USD","IE00BZ08YS42.EUR","LU0348825331.USD","LU0348827113.USD","LU2097828714.EUR","BK1586","09988","LU0791591158.USD","LU0417516738.SGD","LU0577902538.SGD","LU0594300419.USD","LU1224444064.USD","LU0348735423.USD","LU0516423091.SGD","SG9999001689.USD","LU0463099449.HKD","LU0516422952.EUR","LU1688375341.USD","LU0244354667.USD","LU1720051108.HKD","IE00B5MMRT66.SGD","LU0231483743.USD","BK1521","LU1813983027.USD","LU2097828805.USD","LU0588545730.USD","LU0630378429.USD","LU2257852520.SGD","LU1956131251.USD","LU0543330483.HKD","LU0359202008.SGD","LU0169518387.USD","SG9999002463.SGD","603127","LU1807302812.USD","LU0823041008.USD","LU0165289439.USD","LU0254981946.USD","LU0890818403.SGD","LU0828237940.HKD","LU0608807946.USD","LU0577902454.USD","600276","LU0588545490.SGD","LU0128522744.USD","LU0084288322.USD","LU0791590937.USD","LU0329678170.USD","LU0700851271.USD","SG9999004220.SGD","LU0499858438.USD","LU1328277881.USD","LU2449936058.SGD","LU0605514214.HKD","LU1023057109.AUD","01276","LU0307460666.USD","LU0873338254.USD","LU0441854154.USD","LU2097828474.EUR","SHPMY","BK1618","LU0197773673.USD","LU1044875133.USD","LU0314109678.HKD","LU0106959298.USD","LU1720050803.USD","LU0049853897.USD","LU1960683339.HKD","LU0228367735.SGD","LU0477156797.USD","LU0315179316.USD","LU2097828557.USD","HK0000165453.HKD","LU0345775950.USD","LU0543330566.HKD","LU1642822792.SGD","IE0034224299.USD","LU0865486749.SGD","BK1588","SG9999001051.SGD","LU1251922891.USD","LU0823426308.USD","LU0211977185.USD","LU1242518931.SGD","LU0130518102.USD","LU2125910849.SGD","LU0589944569.HKD","LU2357305700.SGD","LU1808992512.USD","LU0048388663.USD","IE00BPRC5H50.USD","LU0163747925.USD","LU0630378692.HKD","IE00B3M56506.USD","BK1161","IE0003895053.USD","LU2039709279.SGD","LU0047713382.USD","LU1810669033.SGD","LU0488056044.USD","LU0531970944.HKD","HK0000320223.HKD","LU1048588211.SGD","LU1048596156.SGD","LU2476274720.SGD","LU0345776255.USD","BK1517","LU0261947096.USD","LU0541502299.USD","LU1769817179.HKD","LU1770034418.SGD","LU1188198961.HKD","LU0052750758.USD","LU0164872284.USD","SG9999001903.USD","LU0540923850.HKD","BABA","SGXZ90724238.SGD","LU0327786744.USD","IE00BZ08YT58.USD","LU0048580855.USD","LU0164880469.USD","LU1993786604.SGD","LU2778985437.USD","SG9999000459.SGD","LU2045819591.USD","LU0823426480.USD","LU0831103253.SGD","601607","LU0862451753.SGD","LU0061477393.USD","LU1868837565.USD","LU2242644610.SGD","LU0456846285.SGD","LU0898667661.SGD","IE00B543WZ88.USD","LU0235996351.USD","LU0831093199.SGD","LU0856984785.SGD","LU0072462343.USD","LU0320764243.SGD","LU2488822045.USD","LU3063872942.SGD","LU1366334578.USD","LU0651947912.USD","02607","LU0128522157.USD","LU0828237510.HKD","LU0611395673.USD","LU0737861772.HKD","LU2152927971.USD","LU0737861699.HKD","LU0348784397.USD","LU0823039010.USD","LU0608807433.USD","LU0708995583.HKD","LU0516422440.USD","LU1366334651.USD","LU0650527681.SGD","BK1583","LU2125910500.SGD","BK1249","LU0541501648.USD","LU1303224171.USD","SG9999001093.SGD","LU1880398554.USD","LU1481107354.HKD","LU1316542783.SGD","LU0054237671.USD","LU1224709979.USD","LU0197773160.USD","LU0329678337.USD","LU0762540952.USD","BK1591","LU0228659784.USD","LU1242518857.USD","LU0640798160.USD","LU1880398471.USD","LU0251144936.SGD","LU0348783233.USD","LU0210526637.USD","IE00B0JY6N72.USD","LU0359201885.HKD","LU1868838027.USD","BK1502","SG9999002828.SGD","LU0043850808.USD","LU0648948544.HKD","LU0106252389.USD","LU1880383440.USD","LU0229945570.USD","IE00BZ08YR35.GBP","LU1201861165.SGD","LU0054450605.USD","LU0181495838.USD","LU1961090484.USD","BK1589","LU0384037296.USD","LU1051769294.HKD","LU1770036033.HKD","LU0140636845.USD","LU0634319403.HKD","LU0370786039.SGD","LU0572940350.SGD","LU1282649810.SGD","LU2476274308.USD","LU0210527791.USD","LU0594300179.USD","HK0000306685.HKD","LU1769817096.USD","LU0823413660.USD","LU0029875118.USD","IE00BMPRXR70.SGD","LU0675040207.SGD","LU0449509016.USD","LU0348805143.USD","LU0259732245.USD","LU0823038988.USD","LU0164865239.USD","BK1501","LU0819121731.USD","LU0264606111.USD","LU0651946864.USD","LU1981816686.USD","LU0261950983.USD"],"gpt_icon":1},{"id":"2607806707","title":"昭衍新药：周志文已减持1497.90万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607806707","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607806707?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:19","pubTimestamp":1769678358,"startTime":"0","endTime":"0","summary":"南财智讯1月29日电，昭衍新药公告，公司实际控制人之一周志文于2026年1月22日至1月28日通过集中竞价及大宗交易方式合计减持公司A股股份14,979,000股，占公司当前总股本的1.99894%，减持计划已提前终止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601293635326997.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","603127","BK1576","BK1141","BK0216"],"gpt_icon":0},{"id":"2606215319","title":"实验猴涨价推动昭衍新药业绩反转，预计2025年扣非净利同比增长超9倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2606215319","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606215319?lang=zh_cn&edition=full","pubTime":"2026-01-26 17:23","pubTimestamp":1769419411,"startTime":"0","endTime":"0","summary":"1月21日，昭衍新药发布了2025年度业绩预告。公司预计实现营业收入约15.73亿元到17.38亿元，较2024年减少约13.9%到22.1%；实现净利润约2.33亿元到3.49亿元，较2024年增加约214%到371%；实现扣非净利润2.46亿元到3.70亿元，较2024年增加约945.2%到1467.7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601263630730329.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601263630730329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","BK1141","BK0216","BK1576","603127"],"gpt_icon":0},{"id":"2606234770","title":"每周股票复盘：昭衍新药（603127）股东周志文减持1010.37万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606234770","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606234770?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:09","pubTimestamp":1769278150,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，昭衍新药报收于41.07元，较上周的42.03元下跌2.28%。交易信息汇总1月23日昭衍新药发生2笔大宗交易，合计成交2.13亿元，折价12.81%。股本股东变化股东增减持1月23日，昭衍新药公告股东周志文于2026年1月22日至23日合计减持1010.37万股，占公司总股本1.3483%。北京昭衍新药研究中心股份有限公司于2026年1月23日收到实际控制人周志文减持股份通知。本次权益变动后，周志文及冯宇霞合计持股比例由32.27%降至30.93%，触及1%权益变动刻度。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000583.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK1576","06127","603127","BK0216"],"gpt_icon":0},{"id":"2605757184","title":"1月23日昭衍新药现2笔折价12.81%的大宗交易 合计成交2.13亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605757184","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605757184?lang=zh_cn&edition=full","pubTime":"2026-01-23 17:49","pubTimestamp":1769161772,"startTime":"0","endTime":"0","summary":"证券之星消息，1月23日昭衍新药发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交5.95万手，折价成交2笔。该股近期无解禁股上市。截至2026年1月23日收盘，昭衍新药报收于41.07元，上涨3.24%，换手率3.33%，成交量20.98万手，成交额8.67亿元。该股近半年内有股东持股变动，合计净减持226.49万股，股东增减持明细如下表：该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家；过去90天内机构目标均价为40.13。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300029915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","BK0216","603127","06127"],"gpt_icon":0},{"id":"2605491486","title":"去年四季度买回昭衍新药、中国东航，中欧基金葛兰：一季度医药板块有望延续结构性行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2605491486","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605491486?lang=zh_cn&edition=full","pubTime":"2026-01-22 21:14","pubTimestamp":1769087660,"startTime":"0","endTime":"0","summary":"2025年末，中欧基金投资总监葛兰在管基金总规模缩水至“300亿元”梯队。1月22日，据最新披露的2025年四季报，葛兰旗下在管基金总规模由去年三季度末的435.44亿元降至去年四季度末的353.89亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601223627662712.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601223627662712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK0188","BK1576","BK1141","159938","BK0053","BK0280","BK0012","BK0028","BK0216","BK0006","06127","BK0183","BK1574","BK0010","600115","BK0196","09939","BK0164","603127","BK0020","BK1515"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773951152235,"stockEarnings":[{"period":"1week","weight":-0.1447},{"period":"1month","weight":-0.2083},{"period":"3month","weight":-0.194},{"period":"6month","weight":-0.2561},{"period":"1year","weight":0.2803},{"period":"ytd","weight":-0.1845}],"compareEarnings":[{"period":"1week","weight":-0.0297},{"period":"1month","weight":-0.0185},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0488},{"period":"1year","weight":0.1693},{"period":"ytd","weight":0.0095}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京昭衍新药研究中心股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2017-08-25","address":"北京市大兴区北京经济技术开发区荣京东街甲5号","registeredCapital":"74934万元","survey":" 北京昭衍新药研究中心股份有限公司的主营业务是以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是药物非临床研究服务、临床服务及其他、实验模型供应。","listedPrice":12.51},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,603127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}